SCHEDULE: Wasatch Advisors Boosts Stake in Journey Medical

Wasatch Advisors LP has increased its beneficial ownership in Journey Medical Corp to 6.7% of common stock, holding over 1.15 million shares.

Summary

• Wasatch Advisors LP, an investment adviser, reported beneficial ownership of 1,152,059 shares of Journey Medical Corp's Common Stock.
• This represents 6.7% of the total class of securities outstanding.
• Wasatch Advisors LP holds sole voting power over 1,045,193 shares and sole dispositive power over all 1,152,059 shares.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Journey Medical Corp.

Sentiment

Score: 7

Explanation: Increased institutional ownership by a reputable investment advisor is generally viewed positively, suggesting confidence in the issuer. However, this filing is purely an ownership disclosure and does not contain operational or financial performance data.

Positives

• Increased institutional ownership by Wasatch Advisors LP, a Delaware-based investment adviser, may signal confidence in Journey Medical Corp's prospects.
• The investment is stated to be for ordinary course of business, indicating a passive, long-term investment strategy rather than an activist one.

Future Outlook

No forward-looking statements or guidance are provided in this ownership disclosure.

Industry Context

This filing indicates an investment firm's increased stake in a medical corporation, reflecting a potential belief in the company's value within the broader healthcare or pharmaceutical sector. Such disclosures are common and provide transparency into institutional investment trends.

Stakeholder Impact

• Shareholders may view the increased institutional ownership as a positive signal, potentially boosting investor confidence and demand for the stock.

Key Dates

Recommendation

The filing indicates increased institutional ownership by Wasatch Advisors LP, a positive signal of confidence. However, a Schedule 13G is purely an ownership disclosure and does not provide fundamental financial or operational data to warrant a stronger recommendation. Investors should consider this alongside other financial reports and market conditions.

Keywords

Journey Medical Corp, Wasatch Advisors, Common Stock, Institutional Ownership, Investment Adviser, Beneficial Ownership, SEC Filing, Schedule 13G